SE9402027D0 - Energy substrates - Google Patents

Energy substrates

Info

Publication number
SE9402027D0
SE9402027D0 SE9402027A SE9402027A SE9402027D0 SE 9402027 D0 SE9402027 D0 SE 9402027D0 SE 9402027 A SE9402027 A SE 9402027A SE 9402027 A SE9402027 A SE 9402027A SE 9402027 D0 SE9402027 D0 SE 9402027D0
Authority
SE
Sweden
Prior art keywords
organs
energy substrates
preparations
interrupted
alpha
Prior art date
Application number
SE9402027A
Other languages
Swedish (sv)
Inventor
Rolf Ekroth
Jan Wernerman
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9402027A priority Critical patent/SE9402027D0/en
Publication of SE9402027D0 publication Critical patent/SE9402027D0/en
Priority to AU27584/95A priority patent/AU2758495A/en
Priority to ZA954775A priority patent/ZA954775B/en
Priority to PCT/SE1995/000698 priority patent/WO1995034301A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention is directed to alpha-ketoglutarate containing infusible energy substrate preparations and the uses thereof. The preparations are advantageous by their capacity in improving the ischemic tolerance of organs interrupted from their regular blood flow and in the improvement of the recovery of such organs.
SE9402027A 1994-06-10 1994-06-10 Energy substrates SE9402027D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9402027A SE9402027D0 (en) 1994-06-10 1994-06-10 Energy substrates
AU27584/95A AU2758495A (en) 1994-06-10 1995-06-09 Energy substrates
ZA954775A ZA954775B (en) 1994-06-10 1995-06-09 Energy substrates
PCT/SE1995/000698 WO1995034301A1 (en) 1994-06-10 1995-06-09 Energy substrates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402027A SE9402027D0 (en) 1994-06-10 1994-06-10 Energy substrates

Publications (1)

Publication Number Publication Date
SE9402027D0 true SE9402027D0 (en) 1994-06-10

Family

ID=20394327

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402027A SE9402027D0 (en) 1994-06-10 1994-06-10 Energy substrates

Country Status (4)

Country Link
AU (1) AU2758495A (en)
SE (1) SE9402027D0 (en)
WO (1) WO1995034301A1 (en)
ZA (1) ZA954775B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859001A (en) 1996-01-11 1999-01-12 University Of Florida Research Foundation, Inc. Neuroprotective effects of polycyclic phenolic compounds
US5880098A (en) * 1996-04-12 1999-03-09 Pharmacia & Upjohn Aktiebolag Therapeutic treatment
PL369552A1 (en) * 2004-08-12 2006-02-20 Sgp & Sons Ab Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions
EP1887862A4 (en) * 2005-05-26 2012-06-06 Ben O'mar Arrington Preservation solution for organs and biological tissues
PL379512A1 (en) * 2006-04-21 2007-10-29 Sgp & Sons Ab New methods and their application
BRPI0814184A2 (en) * 2007-07-02 2015-03-03 Entress Ab USE OF KNOWLEDGE PHARMACOLOGICALLY ACTIVE CHEMICAL COMPOUNDS
US10285962B2 (en) 2016-05-01 2019-05-14 The Regents Of The University Of California Glutarate compounds for treating ischemia-reperfusion injuries
CN113795247B (en) 2018-12-14 2024-04-05 陈益祥 Stable cardioplegia solution for cardiac surgery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3168925D1 (en) * 1980-12-23 1985-03-28 Koehler Chemie Dr Franz Protective solution for heart and kidney, and manufacturing process
DE3785667T2 (en) * 1986-09-17 1994-07-21 Clintec Nutrition Co ADDITIONAL FOOD OR THERAPY FOR PERSONS WITH RISK OR TREATMENT FOR ARTERIOSCLEROTIC VASCULAR, CARDIOVASCULAR AND / OR THROMBOTIC DISEASES.
SE8704217D0 (en) * 1987-10-29 1987-10-29 Vinnars Erik Ab AMINO ACID COMPOSITION FOR PARENTERAL NUTRITION
US4988515A (en) * 1988-01-28 1991-01-29 The Regents Of The Univ. Of Calif. Cardioplegic solution
DE3943424A1 (en) * 1989-12-30 1991-07-04 Nephro Medica Pharma Solns. for intravenous nutrition - contg. alpha-keto acids, for patients with kidney conditions, avoids nitrogen cpd. build-up
SE9201584D0 (en) * 1992-05-20 1992-05-20 Vinnars Erik Ab USE OF ALPHA KETOGLUTARATE

Also Published As

Publication number Publication date
ZA954775B (en) 1996-02-08
AU2758495A (en) 1996-01-05
WO1995034301A1 (en) 1995-12-21

Similar Documents

Publication Publication Date Title
BG102162A (en) Substituted (sulpphinic acid, sulphonic acid, sulphonylamino or sulphinylamino)n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylam ide compounds
FI972628A (en) New sulfonamides
MD1507F2 (en) Inhibitors, pharmaceutical composition on base thereof and process for HIV protease inhibition
DK0912176T3 (en) Use of pyridylalkane, pyridylalkene and / or pyridylalkynic acid amides for the treatment of tumors or immunosuppression
DE69124371D1 (en) TYPE IV DIPEPTIDYL AMINOPEPTIDASE INHIBITORS
DE69331050D1 (en) PRODUCTION OF VIRUS-RESISTANT PLANTS THROUGH THE INTRODUCTION OF NON-TRANSLATABLE VIRAL PLUS-STRAND RNA
NO983529D0 (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
MY141641A (en) Compositions comprising viruses and methods for concentrating virus preparations
DE3581969D1 (en) GENERATION OF SYNTHESIS GAS WITH PREVENTION OF DEPOSITS IN THE DISCHARGE PIPES.
EP0178189A3 (en) Pyridazinone derivatives, their preparation and use
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
SE9402027D0 (en) Energy substrates
FR2431505A1 (en) NOVEL N- (DIAMINOPHOSPHINYL) ARYLCARBOXAMIDES, USEFUL IN PARTICULAR AS UREASE INHIBITORS
ATE76660T1 (en) ENZYMES FOR THE DEGRADATION OF LIGNIN.
ATE19095T1 (en) SURGICAL BINDING SYSTEMS FOR BONDING BODY'S OWN HARD TISSUE WITH PLASTIC AND/OR METAL, IF DESIRED.
DE68917837D1 (en) Peptide compounds.
TR199802538T2 (en) Dihydrobenzopyran and related compounds useful as anti-inflammatory agents.
FI864597A0 (en) CARDIOTONIC THIAZOLONER.
DE3581979D1 (en) ELECTRON BEAM TREATMENT TO INCREASE THE ADHESIVITY OF POLYESTER FILMS.
RU95109909A (en) Method of inhibition of retroviral infection, protease inhibitor, nucleic acid encoding its and a method of recombinant producing serine protease inhibitor
DE69016693D1 (en) Cultivation of transformed microorganisms.
Norling et al. Agents inducing high Mg2+-ATPase activity of isolated coupling factor 1 from spinach chloroplasts
DK184886D0 (en) PROCEDURE FOR THE PREPARATION OF CELL CELL INHIBITORS
MY106261A (en) Anti-inflammatory 1-heteroaryl oxindole-3-carboxamides.
DE68920803D1 (en) Stabilization and reduction of the background fluorescence of hydroxy-coumarin-ester enzyme substrates.